...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: BIO CEO Slides Up
1
Feb 12, 2019 02:14PM
2
Feb 12, 2019 02:23PM
1
Feb 12, 2019 02:28PM
8
Feb 13, 2019 10:21AM
2
Feb 13, 2019 10:36AM
1
Feb 13, 2019 11:36AM
1
Feb 13, 2019 12:00PM
3
Feb 13, 2019 12:06PM

Feb 13, 2019 12:11PM
4
Feb 13, 2019 12:29PM
2
Feb 13, 2019 01:02PM
3
Feb 13, 2019 01:18PM
2
Feb 13, 2019 02:10PM
2
Feb 13, 2019 04:40PM
3
Feb 13, 2019 05:10PM
4
Feb 13, 2019 06:51PM

Following up on this events / 100 patient year thread.

 

For BETonMACE, we now know there were 275 events, 2425 patients, and a median duration of 27 months (2.25 years) /patient. 

275 events / (2425 patients * 2.25 years/patient) = 5.04% Event Rate

Curious if anyone has figured out how close this estimate would be given the other CVOT studies like ELIXA, CANTOS, and EXAMINE.

 

Thanks in advance

 

5
Sep 18, 2019 04:37PM
5
Sep 18, 2019 05:21PM
3
Sep 18, 2019 06:11PM
4
Sep 18, 2019 06:31PM
2
Sep 18, 2019 07:00PM
4
Sep 18, 2019 09:04PM
7
Sep 18, 2019 09:29PM
1
Sep 18, 2019 09:38PM
5
Sep 18, 2019 10:26PM
3
Sep 18, 2019 11:02PM
10
Sep 19, 2019 05:07AM
1
Sep 19, 2019 08:52AM
1
Sep 19, 2019 09:46AM
4
Sep 19, 2019 09:48AM
3
Sep 19, 2019 09:57AM
4
Sep 19, 2019 11:01AM
6
Sep 19, 2019 08:25PM
7
Sep 19, 2019 08:33PM
Share
New Message
Please login to post a reply